Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flos Gossypii Flavonoids in Mild to Moderate Alzheimer's Disease
NCT05269173Phase 2Completed
- Sponsor
- Capital Medical University
- Start
- Oct 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cotton flower total flavonoids in Alzheimer's disease (AD), sponsored by Capital Medical University. Started Oct 2020; status: completed.
02
Drugs
cotton flower total flavonoids
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05269173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269173.